Literature DB >> 20797887

Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review.

Matthew E Falagas1, Nikos Roussos, Konstantinos Z Vardakas.   

Abstract

BACKGROUND: Candidemia is among the leading causes of nosocomial bloodstream infections and is associated with significant mortality. Several centers have published data regarding the incidence and relative frequency of Candida spp.
OBJECTIVE: We performed a systematic review to summarize and evaluate the available evidence regarding the distribution of the relative frequency of Candida spp isolated from blood, according to geographic region and study design, during the period 1996 to 2009.
METHODS: We searched PubMed and Scopus and retrieved 81 relevant articles reporting data on the relative frequency of Candida spp.
RESULTS: C. albicans was the predominant species in almost all studies. The highest proportion of C. albicans was found in North and Central Europe and the USA. Non-albicans species were more common in South America, Asia, and South Europe. C. glabrata was commonly isolated in the USA and North and Central Europe; C. parapsilosis in South America, South Europe, and several parts of Asia; and C. tropicalis in South America and Asia. The relative frequency of C. krusei was low in all regions. Significant differences were noted depending on study design (surveillance study, multicenter or single centre, prospective or retrospective) and setting (hospital or intensive care unit).
CONCLUSIONS: Significant geographic variation is evident among cases of candidemia in different parts of the world. Local epidemiological data continue to be of major significance.
Copyright © 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20797887     DOI: 10.1016/j.ijid.2010.04.006

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  102 in total

1.  Waikialoid A suppresses hyphal morphogenesis and inhibits biofilm development in pathogenic Candida albicans.

Authors:  Xiaoru Wang; Jianlan You; Jarrod B King; Douglas R Powell; Robert H Cichewicz
Journal:  J Nat Prod       Date:  2012-03-08       Impact factor: 4.050

Review 2.  Candida identification: a journey from conventional to molecular methods in medical mycology.

Authors:  Mohammad Zubair Alam; Qamre Alam; Asif Jiman-Fatani; Mohammad Amjad Kamal; Adel M Abuzenadah; Adeel G Chaudhary; Mohammad Akram; Absarul Haque
Journal:  World J Microbiol Biotechnol       Date:  2014-01-01       Impact factor: 3.312

3.  Comparative evaluation of BD Phoenix and vitek 2 systems for species identification of common and uncommon pathogenic yeasts.

Authors:  Brunella Posteraro; Alberto Ruggeri; Elena De Carolis; Riccardo Torelli; Antonietta Vella; Flavio De Maio; Walter Ricciardi; Patrizia Posteraro; Maurizio Sanguinetti
Journal:  J Clin Microbiol       Date:  2013-08-21       Impact factor: 5.948

4.  Epidemiological Trends of Fungemia in Greece with a Focus on Candidemia during the Recent Financial Crisis: a 10-Year Survey in a Tertiary Care Academic Hospital and Review of Literature.

Authors:  Maria Siopi; Aikaterini Tarpatzi; Eleni Kalogeropoulou; Sofia Damianidou; Alexandra Vasilakopoulou; Sophia Vourli; Spyros Pournaras; Joseph Meletiadis
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

5.  Discrimination of Candida albicans from Candida dubliniensis by Use of the BioFire FilmArray Blood Culture Identification Panel.

Authors:  Timothy R Southern; Aqilah Alelew; Peter C Iwen
Journal:  J Clin Microbiol       Date:  2015-04-15       Impact factor: 5.948

Review 6.  Candida parapsilosis and the neonate: epidemiology, virulence and host defense in a unique patient setting.

Authors:  Brian D W Chow; Jennifer R Linden; Joseph M Bliss
Journal:  Expert Rev Anti Infect Ther       Date:  2012-08       Impact factor: 5.091

7.  Small-molecule suppressors of Candida albicans biofilm formation synergistically enhance the antifungal activity of amphotericin B against clinical Candida isolates.

Authors:  Jianlan You; Lin Du; Jarrod B King; Brian E Hall; Robert H Cichewicz
Journal:  ACS Chem Biol       Date:  2013-02-14       Impact factor: 5.100

8.  Development and validation of an in-house database for matrix-assisted laser desorption ionization-time of flight mass spectrometry-based yeast identification using a fast protein extraction procedure.

Authors:  Elena De Carolis; Antonietta Vella; Luisa Vaccaro; Riccardo Torelli; Patrizia Posteraro; Walter Ricciardi; Maurizio Sanguinetti; Brunella Posteraro
Journal:  J Clin Microbiol       Date:  2014-02-19       Impact factor: 5.948

9.  Isolation and drug susceptibility of Candida parapsilosis sensu lato and other species of C. parapsilosis complex from patients with blood stream infections and proposal of a novel LAMP identification method for the species.

Authors:  Plinio Trabasso; Tetsuhiro Matsuzawa; Renata Fagnani; Yasunori Muraosa; Kenichiro Tominaga; Mariangela Ribeiro Resende; Katsuhiko Kamei; Yuzuru Mikami; Angelica Zaninelli Schreiber; Maria Luiza Moretti
Journal:  Mycopathologia       Date:  2014-12-07       Impact factor: 2.574

10.  Candida tropicalis Biofilms: Biomass, Metabolic Activity and Secreted Aspartyl Proteinase Production.

Authors:  Melyssa Negri; Sónia Silva; Isis Regina Grenier Capoci; Joana Azeredo; Mariana Henriques
Journal:  Mycopathologia       Date:  2015-11-16       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.